KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Other Operating Expenses (2016 - 2025)

Evolent Health (EVH) has 11 years of Other Operating Expenses data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $1.2 million; the TTM value through Dec 2025 reached -$676000.0, up 96.42%, while the annual FY2025 figure was -$676000.0, 96.42% up from the prior year.
  • Other Operating Expenses reached $1.2 million in Q3 2025 per EVH's latest filing, up from -$1.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $488.4 million in Q4 2023 and bottomed at -$18.9 million in Q4 2024.
  • Average Other Operating Expenses over 5 years is $165.2 million, with a median of $179.7 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: surged 360939.73% in 2022, then tumbled 103.87% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $73000.0 in 2021, then soared by 360739.73% to $263.4 million in 2022, then skyrocketed by 85.4% to $488.4 million in 2023, then plummeted by 103.87% to -$18.9 million in 2024, then skyrocketed by 106.51% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $1.2 million in Q3 2025, -$1.9 million in Q1 2025, and -$18.9 million in Q4 2024.